Skip to main content
. 2017 Mar 29;23(5):438–446. doi: 10.1111/cns.12692

Figure 4.

Figure 4

Reversal of the inhibitory effects of 5′Cl5′d‐(±)‐ENBA (0.1 mg/kg) on the harmaline‐induced tremor and hyperactivity by DPCPX (1 mg/kg). The number of animals: vehicle, n=10; HARM, n=10; 5′Cl‐ENBA 0.1+HARM, n=12; DPCPX 1+5′Cl‐ENBA 0.1+HARM, n=12. Statistics: ANOVA for repeated measures+LSD post hoc test. *P<.05, **P<.01, ***P<.001 vs vehicle; # P<.05, ## P<.01, ### P<.001 vs HARM, ^ P=.065 vs HARM; & P<.05, &&& P<.001 vs 5′Cl‐ENBA 0.1+HARM. For further details, see Figures 1 and 2